Curcumin nanoparticles are a promising anti-bacterial and anti-inflammatory agent for treating periprosthetic joint...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Infectious Diseases

Background:

• Periprosthetic joint infections (PJIs) are recurrent complications of joint replacement surgery, often resistant to conventional treatments.
• Curcumin, a natural compound, possesses anti-inflammatory and antibacterial properties but suffers from poor water solubility, limiting its clinical use.
• Curcumin nanoparticles (CURN) were engineered to enhance curcumin's bioavailability and therapeutic potential.

Purpose of the Study:

• To investigate the therapeutic efficacy and anti-inflammatory mechanisms of CURN in a Staphylococcus aureus biofilm-induced PJI model.
• To evaluate CURN's impact on immune cell modulation and its synergistic effects with antibiotics.

Main Methods:

• Establishment of a Staphylococcus aureus biofilm-induced PJI model in vivo.
• Administration of CURN to assess its effects on myeloid-derived suppressor cells (MDSCs) and their polarization (M1/M2).
• Analysis of cytokine and reactive oxygen species levels to elucidate CURN's mechanism of action on T cell proliferation.
• Evaluation of bone destruction recovery and vancomycin therapeutic enhancement by CURN.

Main Results:

• CURN significantly attenuated the expansion of MDSCs induced by S. aureus biofilms.
• CURN modulated M1 and M2 phenotypic MDSC expression and downregulated pro-inflammatory cytokines and reactive oxygen species.
• The mechanism involved reversing T cell proliferation suppression, leading to the recovery of bone permeative destruction.
• CURN demonstrated enhanced therapeutic potency when combined with vancomycin in vivo.

Conclusions:

• This research presents the first evidence of CURN's potential utility in treating PJIs.
• CURN exhibits promising anti-inflammatory and immunomodulatory effects beneficial for PJI management.
• CURN may serve as a novel therapeutic agent to improve outcomes for patients with periprosthetic joint infections.